Literature DB >> 23175231

Factors affecting T cell responses induced by fully synthetic glyco-gold-nanoparticles.

Silvia Fallarini1, Tiziana Paoletti, Carolina Orsi Battaglini, Paolo Ronchi, Luigi Lay, Renato Bonomi, Satadru Jha, Fabrizio Mancin, Paolo Scrimin, Grazia Lombardi.   

Abstract

We have synthesized and characterized nearly monodisperse and highly pure gold nanoparticles (2 and 5 nm) coated with non-immunoactive mono- and disaccharides, modelled after the capsular polysaccharide of serogroup A of the Neisseria meningitidis bacterium. We have used them to test their ability to induce immune cell responses as a consequence of their multivalency. The results indicate that they are indeed immunoactive and that immunoactivity is strongly dependent on size, and larger, 5 nm nanoparticles perform far better than smaller, 2 nm ones. Immune response (activation of macrophages) initiates with the whole nanoparticle recognition by the surface of antigen-presenting cells, independent of the saccharide oligomerization (or charge) on the nanoparticle surface. The induction of T cell proliferation and the increase of IL-2 levels, a consequence of the expression of MHC II involved in antigen presentation, require the presence of a disaccharide on the nanoparticle, not just a monosaccharide. A possible explanation is that, at this stage, the saccharides are detached from the gold surface. These results may provide leads for designing new saccharide-based, nanoparticle-conjugate vaccines.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23175231     DOI: 10.1039/c2nr32338a

Source DB:  PubMed          Journal:  Nanoscale        ISSN: 2040-3364            Impact factor:   7.790


  13 in total

Review 1.  Tumor-associated macrophages: Role in the pathological process of tumorigenesis and prospective therapeutic use (Review).

Authors:  Olga V Zhukova; Tatiana F Kovaleva; Evgenia V Arkhipova; Sergey A Ryabov; Irina V Mukhina
Journal:  Biomed Rep       Date:  2020-08-28

Review 2.  Nanotechnology in Glycomics: Applications in Diagnostics, Therapy, Imaging, and Separation Processes.

Authors:  Erika Dosekova; Jaroslav Filip; Tomas Bertok; Peter Both; Peter Kasak; Jan Tkac
Journal:  Med Res Rev       Date:  2016-11-15       Impact factor: 12.944

3.  Immunological properties of gold nanoparticles.

Authors:  Lev A Dykman; Nikolai G Khlebtsov
Journal:  Chem Sci       Date:  2016-11-16       Impact factor: 9.825

Review 4.  Glyco-gold nanoparticles: synthesis and applications.

Authors:  Federica Compostella; Olimpia Pitirollo; Alessandro Silvestri; Laura Polito
Journal:  Beilstein J Org Chem       Date:  2017-05-24       Impact factor: 2.883

Review 5.  Gold nanoparticle mediated cancer immunotherapy.

Authors:  Joao Paulo Mattos Almeida; Elizabeth Raquel Figueroa; Rebekah Anna Drezek
Journal:  Nanomedicine       Date:  2013-10-05       Impact factor: 5.307

6.  Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed TH1-TH17 Immunity, Correlated with Increased Protection against Burkholderia pseudomallei.

Authors:  Daniel Tapia; Javier I Sanchez-Villamil; Heather L Stevenson; Alfredo G Torres
Journal:  mBio       Date:  2021-06-29       Impact factor: 7.867

Review 7.  Immunomodulation of nanoparticles in nanomedicine applications.

Authors:  Qing Jiao; Liwen Li; Qingxin Mu; Qiu Zhang
Journal:  Biomed Res Int       Date:  2014-05-20       Impact factor: 3.411

Review 8.  Multivalent nanosystems: targeting monocytes/macrophages.

Authors:  Rémy Poupot; Cécile Goursat; Séverine Fruchon
Journal:  Int J Nanomedicine       Date:  2018-09-19

Review 9.  Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development.

Authors:  Cinzia Colombo; Olimpia Pitirollo; Luigi Lay
Journal:  Molecules       Date:  2018-07-13       Impact factor: 4.411

Review 10.  Glyconanoparticles as tools to prevent antimicrobial resistance.

Authors:  Laura Morelli; Laura Polito; Barbara Richichi; Federica Compostella
Journal:  Glycoconj J       Date:  2021-03-17       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.